MCKESSON CORP business relationships
Companies named in MCKESSON CORP’s 10-K filed 2026-05-08, and public companies whose annual reports name MCKESSON CORP. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.1 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in MCKESSON CORP’s annual report 3
“Sales to our largest customer, CVS Health Corporation ("CVS"), accounted for approximately 24% of our total consolidated revenues in fiscal 2026.” SEC filing
“In fiscal 2023, we extended our pharmaceutical distribution partnership with CVS to June 2027.” SEC filing
“We also source generic pharmaceutical drugs through our ClarusONE Sourcing Services LLP joint venture with Walmart Inc. ("ClarusONE").” SEC filing
Companies whose annual reports name MCKESSON CORP 32
“Our product sales to three large wholesalers, McKesson Corporation, Cencora, Inc. and Cardinal Health, Inc., each individually accounted for more than 10% of total revenues for each of the years 2025, 2024 and 2023.” SEC filing
“(1) As of December 31, 2025, the majority of our Accounts receivable balance arises from product sales in the U.S. and Europe and approximately 60 % relates to three wholesalers-Cardinal Health, Cencora and McKesson-and their specialty distributor affiliates.” SEC filing
“The Company's customers with the largest accounts receivable balances are: McKesson Corporation, Cencora, Inc. and Cardinal Health, Inc., which represented approximately 22 %, 21 % and 13 %, respectively, of total accounts receivable at December 31, 2025.” SEC filing
“The sales to McKesson Group and Cencora Group were JPY 592,323 million, JPY 577,017 million, respectively, for the year ended March 31, 2025.” SEC filing
“In the fiscal year ended March 31, 2026, there were two wholesale distributors, McKesson Group and Cencora Group, that each individually accounted for over ten percent of Takeda's total revenue.” SEC filing
“For the year ended December 31, 2025, our four largest customers, Cencora, Inc., McKesson Drug Co., Cardinal Health, Inc., and CVS Health Corporation, collectively accounted for approximately 71% of our consolidated net revenue.” SEC filing
“For example, large wholesalers and retailer customers have formed alliances, such as Walgreens and Cencora, Inc., Rite Aid and McKesson Drug Company, and CVS Caremark and Cardinal Health.” SEC filing
“In 2025, 2024, and 2023, three wholesale distributors in the U.S.-McKesson Corporation, Cencora, Inc., and Cardinal Health, Inc.-each accounted for a significant percentage of our consolidated revenue.” SEC filing
“The Company's customers with the largest accounts receivable balances are McKesson Corporation and Cencora, Inc., which represented approximately 14 % and 7 %, respectively, of total gross accounts receivable at December 31, 2025.” SEC filing
“In addition, we rely heavily on the three largest pharmaceutical wholesalers in the U.S. market-Cardinal Health Inc., Cencora, and McKesson Corp-in the distribution of ARISTADA and ARISTADA INITIO, LYBALVI and VIVITROL.” SEC filing
“We conduct business with the three major wholesalers in the U.S.: Cencora, Inc., Cardinal Health, and McKesson.” SEC filing
“The Company has Distribution Services Agreements ("DSAs") with several large wholesale customers such as McKesson Corporation, Cencora Inc., Cardinal Health, Inc. and McKesson Specialty.” SEC filing
“Our primary wholesale distributor relationships currently include Cardinal Health, Inc., McKesson Corporation, Smith Drug Company, and Morris and Dickson Co. L.L.C., in addition to various generic drug manufacturers.” SEC filing
“We had three wholesalers each comprising 10 percent or more of our total revenue for the year ended December 31, 2025: McKesson Drug Company, Cardinal Health, Inc. and AmerisourceBergen Health Corporation, which accounted for 31%, 26% and 22% of our total revenues, respectively.” SEC filing
“...gram under which orders are processed through wholesalers (including AmerisourceBergen Health Corporation, Cardinal Health, Inc. and McKesson Drug Company), but shipments of the product are sent directly to individual accounts, such as hospitals, ambulatory surgery centers and individual physicians.” SEC filing
“During the year ended December 31, 2025, approximately 99% of LOQTORZI revenues were from three large wholesale distributors: McKesson Corporation , Cencora, Inc., and Cardinal Health, Inc.” SEC filing
“As of December 31, 2025, five customers accounted for 81 % of gross accounts receivable, including ESSDS, which accounted for 41 % of gross accounts receivable, ASD, which accounted for 16 % of gross accounts receivable and McKesson, which accounted for 11 % of gross accounts receivable.” SEC filing
“Defitelio is sold to hospital customers through subsidiary specialty distributors of McKesson.” SEC filing
“For the year ended December 31, 2024, sales to our three largest customers, Kedrion, Takeda and McKesson, one of the largest U.S.-based” SEC filing
“Progressive had significant concentrations with one vendor, McKesson.” SEC filing
“Our specialty distributor network sells to hospitals, physician practices and other sites of care and consists of McKesson, ASD/Oncology Supply, Cardinal Health, DMS Pharmaceutical Group and Bio Care.” SEC filing
“Each of our three major customers, Cencora, Inc., Cardinal Health, Inc., and McKesson Corporation, individually accounted for more than 15% of our total product revenue in 2025 and collectively accounted for more than 76% of our total product revenue in 2025.” SEC filing
“In 2025, three wholesale distributors (McKesson Corporation, Cardinal Health, Inc. and Cencora, Inc.) accounted for substantially all of AbbVie's pharmaceutical product sales in the United States.” SEC filing
“...ded December 31, 2025, sales to the Company ' s three largest product distributors, ASD Specialty Healthcare (Cencora), McKesson and Shanghai Pharmaceutical represented approximately 18.5 %, 17.5 % and 10.1 % of product revenue, respectively, and collectively, represented approximately 37.1 % of tra...” SEC filing
“We currently contract with multiple pharmaceutical distributors throughout the United States, including McKesson Corporation ("McKesson"), Cardinal Health 110, LLC ("Cardinal Health 110") and AmerisourceBergen Corporation ("AmerisourceBergen").” SEC filing
“From 2017 to 2019, GX-03 was commercially distributed by McKesson for wound” SEC filing
“In addition, Citius Oncology has entered into distribution agreements with Cardinal Health, Cencora and McKesson” SEC filing
“For example, for the fiscal year ended September 30, 2025, gross sales to Cencora, McKesson Corporation, and Cardinal Health, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.” SEC filing
“For the fiscal year ended September 30, 2025, McKesson Corporation, Cardinal Health and Cencora, Embecta's three largest distributors, together represented approximately 42% of Embecta's worldwide gross sales.” SEC filing
“four pharmaceutical product wholesaler distributors: McKesson Corporation, Cencora Inc., Western Wellness and Cardinal Health, Inc. These” SEC filing
“LYMPHIR, we have entered into distribution agreements with Cardinal Health, Cencora and McKesson Corporation.” SEC filing
“Additionally, other distributors of med-surg products similarly connect the fragmented supplier and provider bases and aggregate inventory from suppliers to deliver products to customers, such as McKesson, Cardinal Health, Owens & Minor, and Henry Schein.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.